A proposal for improvement of the first-line treatment of advanced diabetic retinopathy
Meyer Elazar
Additional contact information
Meyer Elazar: 214 Haalon St., Matta, Israel
Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990, 2025, vol. 13, 189-195
Abstract:
Diabetic retinopathy (DR) can be resulted from high blood glucose levels that may damage the retinal pigment epithelium, located between the vascular choroids and the neurosensory retina, which functions as a barrier. The first-line treatment of DR comprises an anti-vascular endothelial growth factor (anti-VEGF) compound such as Avastin (bevacizumab), Lucentis (ranibizumab) and Eylea (aflibercept). Some patients suffering from static condition of advanced DR need a treatment that will lead to improvement of the DR condition, e.g., reduction of abnormal blood vessels on the optic disc and preventing further ischemic optic neuropathy. Thus, a combined simultaneous treatment of an anti-VEGF compound such as Avastin, or a biosimilar version, and oral administration of fucoxanthin that has a protective effect on the retina, optionally together with vitamin A, is proposed for treating advanced DR.
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://techniumscience.com/index.php/biochemmed/article/view/13255 (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:tec:bioche:ojs:13255
DOI: 10.47577/biochemmed.v13i.13255
Access Statistics for this article
Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990 is currently edited by Anna Maria Golita
More articles in Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990 from Technium Science
Bibliographic data for series maintained by Anna Maria Golita ().